Literature DB >> 6789678

Light chain nephropathy.

R R Tubbs, G N Gephardt, J T McMahon, P M Hall, R Valenzuela, D G Vidt.   

Abstract

In 13 specimens of renal tissue from 11 patients, deposits of monoclonal immunoglobulin light chains and continuous granular electron-dense material within tubular basement membranes and in association with the glomerular basement membrane were identified. All but one patient were men n the fifth to seventh decades of life, and each presented with azotemia and features of glomerular rather than tubulointerstitial disease. Osteolytic bone lesions occurred in only three patients, and a bone marrow plasmacytosis greater than 30 percent consistent with plasma cell myeloma was identified in only four patients. Light chain distribution in the nephron was confirmed with immunoelectron microscopy and was not associated with deposition of other serum proteins such as immunoglobulin heavy chains, complement, transferrin, alpha 2 macroglobulin and albumin. The electron dense deposits differed in distribution and character from those associated with membranoproliferative glomerulonephritis type II (dense deposit disease), amyloidosis, cryoglobulinemia, macroglobulinemia and benign monoclonal gammopathy. Serum from six of these patients did not bind to normal human or rat renal parenchyma in vitro. Kappa light chain nephropathy was characterized by predominant linear tubular basement membrane kappa deposits, and nodular mesangial and linear glomerular basement membrane kappa immunostaining. Lambda light chain nephropathy was characterized by linear lambda glomerular basement membrane and tubular basement membrane immunostaining. Manifestations of glomerular dysfunction dominated the clinical presentation of light chain nephropathy, and most patients did not have typical features of multiple myeloma. The diagnosis was predicated upon thorough immmunohistologic assessment of renal biopsy material.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789678     DOI: 10.1016/0002-9343(81)90127-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient.

Authors:  M P Grassi; F Clerici; C Perin; M Borella; A Gendarini; A Quattrini; R Nemni; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy.

Authors:  C Delaporte; B Varet; M Fardeau; D Nochy; A Ract
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Light chains and the kidney.

Authors:  J R Bradley; S Thiru; D B Evans
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

4.  Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy.

Authors:  M M Silver; S A Hearn; S Ritchie; R P Slinger; J A Sholdice; P S Cordy; A B Hodsman
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

5.  Systemic lambda light-chain deposition presenting with predominant cardiac involvement.

Authors:  M J Garton; S Walton; S W Ewen
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 6.  Renal lesions in dysproteinemias.

Authors:  P Verroust; L Morel-Maroger; J L Preud'Homme
Journal:  Springer Semin Immunopathol       Date:  1982

7.  Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.

Authors:  M M Silver; S A Hearn; J C Walton; L A Lines; V M Walley
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

Review 8.  Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors:  Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

9.  [Successful treatment of kappa light chain nephropathy using membrane plasma separation].

Authors:  K B Sprenger; J Galle; I Sprenger-Klasen; J M Herrmann; H E Franz
Journal:  Klin Wochenschr       Date:  1984-10-01

10.  Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.

Authors:  Magali Colombat; Hervé Mal; Christiane Copie-Bergman; Jacques Diebold; Diane Damotte; Patrice Callard; Michel Fournier; Jean-Pierre Farcet; Marc Stern; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.